Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHA:603882)

China · Delayed Price · Currency is CNY

26.69

+0.32 (1.21%)

Jul 20, 2026, 3:00 PM CST

-9.74% (1Y)

Market Cap	12.36B -9.7%
Revenue (ttm)	5.91B -13.2%
Net Income	-102.67M
EPS	-0.22
Shares Out	463.26M
PE Ratio	n/a
Forward PE	31.22
Dividend	0.88 (3.34%)
Ex-Dividend Date	Feb 5, 2026

Volume	9,919,400
Open	26.30
Previous Close	26.37
Day's Range	26.00 - 26.85
52-Week Range	21.50 - 40.68
Beta	0.47
Analysts	Buy
Price Target	30.49 (+14.24%)
Earnings Date	Aug 25, 2026

About SHA:603882

Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides medical health check-up, medical cold chain logistics, and other services, as well as sells diagnostic products. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2006

Employees 9,529

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603882

Full Company Profile

Financial Performance

In 2025, SHA:603882's revenue was 6.03 billion, a decrease of -16.12% compared to the previous year's 7.19 billion. Losses were -173.24 million, -54.56% less than in 2024.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 603882 stock is "Buy." The 12-month stock price target is ¥30.49, which is an increase of 14.24% from the latest price.

Price Target

¥30.49

(14.24% upside)

Analyst Consensus: Buy

Stock Forecasts